Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients

Neoplasia : an International Journal for Oncology Research
Yang LiuPhouthone Keohavong

Abstract

Aberrant methylation in gene promoter regions leads to transcriptional inactivation of cancer-related genes and plays an integral role in tumorigenesis. This alteration has been investigated in lung tumors primarily from smokers, whereas only a few studies involved never-smokers. Here, we applied methylation-specific polymerase chain reaction to compare the frequencies of the methylated promoter of p16 and O6-methylguanine-DNA methyltransferase (MGMT) genes in lung tumors from 122 patients with non-small cell lung cancer, including 81 smokers and 41 never-smokers. Overall, promoter methylation was detected in 52.5% (64 of 122) and 30.3% (37 of 122) of the p16 and MGMT genes, respectively. Furthermore, the frequency of promoter methylation was significantly higher among smokers, compared with never-smokers, for both the p16 [odds ratio (OR) = 3.28; 95% confidence interval (CI) = 1.28-8.39; P = .013] and MGMT (OR = 3.93; 95% CI = 1.27-12.21; P = .018) genes. The trend for a higher promoter methylation frequency of these genes was also observed among female smokers compared with female never-smokers. Our results suggest an association between tobacco smoking and an increased incidence of aberrant promoter methylation of the p16 an...Continue Reading

References

Jan 9, 1987·Science·J L MumfordJ C Chuang
Nov 18, 1994·Cell·C J Sherr
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Feb 1, 1996·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·P KeohavongJ M Siegfried
Mar 24, 2000·Trends in Genetics : TIG·S B Baylin, J G Herman
Aug 24, 2001·International Journal of Cancer. Journal International Du Cancer·N OueW Yasui
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Shinichi ToyookaAdi F Gazdar
Dec 4, 2004·International Journal of Cancer. Journal International Du Cancer·Kevin K DivineSteven A Belinsky
Feb 19, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P Boyle, J Ferlay
Mar 3, 2005·Journal of the National Cancer Institute·Hisayuki ShigematsuAdi F Gazdar

❮ Previous
Next ❯

Citations

Feb 12, 2008·Journal of Applied Genetics·Paweł KarpińskiNikolaus Blin
Nov 19, 2009·Journal of Biosciences·Scott F Gilbert
May 26, 2009·Pathology Oncology Research : POR·Safiye AktasNur Olgun
Mar 23, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jing WenMing Guo
Jun 12, 2013·Carcinogenesis·Zdenko HercegChristopher P Wild
Nov 10, 2012·Molecular Human Reproduction·Melissa A SuterKjersti M Aagaard
Oct 29, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mariana BraitMohammad Obaidul Hoque
Oct 14, 2011·Future Oncology·Szilvia TorokGyula Ostoros
Jul 5, 2012·Journal of Toxicology and Environmental Health. Part a·Houbing DuJianxiang Li
May 18, 2011·Journal of Oncology·Alexander SalskovHubert Vesselle
Nov 19, 2010·Virchows Archiv : an International Journal of Pathology·Micaela PoetschChris Protzel
Jul 11, 2014·Cellular Oncology (Dordrecht)·Adfar YousufSyed Mudassar
Jun 18, 2014·Journal of Cancer Research and Clinical Oncology·Matjaz VogelsangM Iqbal Parker
Dec 3, 2011·Expert Review of Molecular Diagnostics·Shahnaz Begum
Aug 24, 2013·Expert Review of Respiratory Medicine·Michael FleischhackerBernd Schmidt
Sep 1, 2007·Expert Opinion on Medical Diagnostics·Ashley G Rivenbark, William B Coleman
Oct 1, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kit W TamAdi Gazdar
Nov 8, 2011·Clinics in Chest Medicine·Jill E Larsen, John D Minna
Sep 29, 2011·Seminars in Cancer Biology·Anabelle Decottignies, Fabrizio d'Adda di Fagagna
Dec 18, 2007·Neoplasia : an International Journal for Oncology Research·Takako KawasakiShuji Ogino
Nov 1, 2007·Neoplasia : an International Journal for Oncology Research·Wei-Wei ShenGuo-Hui Fu
Jan 29, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Young Joo LeeByoung Chul Cho
Sep 4, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hiroyuki YasudaAkitoshi Ishizaka
Sep 11, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Pei-Fang WuChing-Hung Lin
Jul 5, 2008·The Lancet Oncology·Janakiraman Subramanian, Ramaswamy Govindan
Feb 25, 2015·Mechanisms of Ageing and Development·Michele ZampieriPaola Caiafa
Nov 27, 2014·Epigenetics : Official Journal of the DNA Methylation Society·Loukia G TsaprouniPanos Deloukas
Jul 16, 2008·International Journal of Cancer. Journal International Du Cancer·Masafumi TakeshitaKatsuo Sueishi
Nov 13, 2008·Risk Analysis : an Official Publication of the Society for Risk Analysis·Louis Anthony Cox
Jun 22, 2007·International Journal of Cancer. Journal International Du Cancer·Ian M SmithJoseph A Califano
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Takaomi KogaKatsuo Sueishi
Dec 19, 2009·International Journal of Cancer. Journal International Du Cancer·Hua TianGuo-Hui Fu
Apr 2, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Scott M LangevinKarl T Kelsey
Apr 2, 2016·Briefings in Functional Genomics·Fu-Hui XiaoYong-Han He
Oct 6, 2010·Head & Neck Oncology·Astrid L KruseKlaus W Grätz
Jun 14, 2016·BioMed Research International·Estela G TorañoAgustín F Fernández

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Related Papers

International Journal of Cancer. Journal International Du Cancer
Kevin K DivineSteven A Belinsky
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
A Mazin SafarChun-Yang Fan
© 2021 Meta ULC. All rights reserved